Search results
Moderna Inc [MRNA] Shares Fall
Knox Daily· 5 days agoGenuity has initiated its “Hold” rating for MRNA. Earlier on November 03, 2023, HSBC Securities upgraded its rating. Their new recommendation was “a Hold” for MRNA ...
J.W. Cole Advisors Inc. Purchases 174 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoCole Advisors Inc. lifted its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing ...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks· 2 days agoInvestors can't control the latter, but they can focus on a company's earnings results every quarter. This means that investors might want to take advantage of these earnings surprises. Now ...
Baillie Gifford's Strategic Moves in Q1 2024: A Closer Look at NVIDIA Corp's Adjustment
GuruFocus.com via Yahoo Finance· 3 hours ago(NYSE:NIO) shares were reduced by 95,730,817, an -83.51% decrease, impacting the portfolio by...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 6 days agoWhat's Going On With Pfizer Stock On Thursday?
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 1 day agoPfizer PFE is scheduled to release its first-quarter earnings report before the opening bell on May...
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com
Investing.com· 5 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant portion of his...
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 1 day agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
2 Top Growth Stocks to Buy Right Now and Hold Forever
Motley Fool via Yahoo Finance· 3 days agoBroadly speaking, healthcare companies provide products and solutions that people need no matter...
Biotech Stocks Facing FDA Decision In May 2024
RTT News· 1 day agoAs April comes to an end, attention shifts to biotech stocks poised for regulatory events in May. The FDA approved eight novel drugs last May, contributing to a total of 55 approvals in 2023 ...
